Pro-Dex (NASDAQ:PDEX) Posts Quarterly Earnings Results, Beats Expectations By $0.11 EPS

Pro-Dex (NASDAQ:PDEX) issued its quarterly earnings data on Thursday. The medical instruments supplier reported $0.46 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.11, Yahoo Finance reports. Pro-Dex had a return on equity of 6.50% and a net margin of 4.13%. The business had revenue of $15.03 million for the quarter.

Pro-Dex Trading Up 4.6 %

Pro-Dex stock opened at $23.28 on Friday. Pro-Dex has a 52 week low of $14.51 and a 52 week high of $24.74. The company has a debt-to-equity ratio of 0.25, a quick ratio of 2.08 and a current ratio of 3.45. The firm has a market capitalization of $79.62 million, a PE ratio of 40.14 and a beta of 0.38. The business’s 50-day simple moving average is $19.73 and its 200-day simple moving average is $18.85.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Pro-Dex from a “buy” rating to a “strong-buy” rating in a research note on Saturday.

Insider Activity at Pro-Dex

In related news, Director Angelita Rebamontan Domingo sold 2,585 shares of the business’s stock in a transaction on Monday, June 24th. The shares were sold at an average price of $18.30, for a total transaction of $47,305.50. Following the transaction, the director now owns 8,191 shares of the company’s stock, valued at $149,895.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 42.60% of the stock is owned by corporate insiders.

Pro-Dex Company Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.